Bruce Car - 05 Jan 2026 Form 4 Insider Report for Biohaven Ltd. (BHVN)

Reporting relationship: Chief Scientific Officer
Issuer ticker: BHVN
Reported as of: 05 Jan 2026
Net transaction value: -$23,643
SEC form: 4
Accepted by SEC: 07 Jan 2026, 21:32:04 UTC
Prior SEC filing: 07 Jan 2025
Next SEC filing: 03 Mar 2026
Source filing: View source filing
Reporting owner signature: /s/ George Clark, Attorney-in-Fact

Key filing fact

Bruce Car filed Form 4 for Biohaven Ltd. (BHVN) on 07 Jan 2026.

Key facts

This page summarizes Bruce Car's Form 4 filing for Biohaven Ltd. (BHVN).
3 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 07 Jan 2026, 21:32.

Change

Previous filing in this sequence was filed on 07 Jan 2025.
Current net transaction value: -$23,643.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001798876 Primary reporting owner

Car Bruce

Relationship: Chief Scientific Officer
Address: C/O BIOHAVEN LTD., 215 CHURCH STREET, NEW HAVEN
Signature: /s/ George Clark, Attorney-in-Fact
Signature date: 07 Jan 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BHVN transaction

Common Shares

Options Exercise

Transaction value: $0
Shares: +4,750
Change %: +89%
Price: $0.000000
Shares after: 10,096
Date: 05 Jan 2026
Ownership: Direct
Footnotes: F1

BHVN transaction

Common Shares

Tax liability

Transaction value: $23,643
Shares: -2,381
Change %: -24%
Price: $9.93
Shares after: 7,715
Date: 05 Jan 2026
Ownership: Direct
Footnotes: F1, F2

BHVN holding

Common Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 30,000
Date: 05 Jan 2026
Ownership: By IRA

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

BHVN transaction Derivative

Restricted Share Unit Award

Options Exercise

Transaction value: $0
Shares: -4,750
Change %: -33%
Price: $0.000000
Shares after: 9,500
Date: 05 Jan 2026
Ownership: Direct
Underlying class: Common Shares
Underlying amount: 4,750
Exercise price
Footnotes: F3, F4, F5

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 5 footnotes

Footnote F1

This balance includes 544 shares that were acquired through the Biohaven Employee Share Purchase Plan on May 31, 2025.

Footnote F2

No shares were sold - these shares were withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted share units.

Footnote F3

Each restricted share unit represents the contingent right to receive one common share of the Issuer.

Footnote F4

The reporting person was granted 19,000 restricted share units on January 5, 2025, vesting in four equal installments on January 5, 2025, 2026, 2027 and 2028, subject to the reporting person's continued service with the Issuer at each vesting date.

Footnote F5

Not applicable.